Retinitis Stocks List Ranked for 2024 | NYSE,

Symbol	Grade	Name	% Change
OCGN	F	Ocugen, Inc.	-1.92
EYPT	D	EyePoint Pharmaceuticals, Inc.	-6.76
RGNX	D	REGENXBIO Inc.	-4.67
BNTC	C	Benitec Biopharma Limited	-4.32
GILD	C	Gilead Sciences, Inc.	1.27

Symbol	Grade	Name	Weight
BBH	D	Market Vectors Biotech ETF	10.89
IBBQ	D	Invesco Nasdaq Biotechnology ETF	10.05
IBB	D	iShares Nasdaq Biotechnology Index Fund	9.82
BIS	B	ProShares UltraShort Nasdaq Biotechnology	7.62
BIB	F	ProShares Ultra Nasdaq Biotechnology	7.6

Compare ETFs

Compare BBH to IBBQ Compare IBB to BIS Compare IBBQ to IBB

Date	Stock	Title
Nov 20	GILD	Gilead Sciences, Inc. (GILD) Jefferies London Healthcare Conference (Transcript)
Nov 20	OCGN	Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate OCU410ST for Treatment of ABCA4-Associated Retinopathies including Stargardt Disease
Nov 19	OCGN	Ocugen reports positive data for OCU400, OCU410
Nov 19	OCGN	Ocugen Announces Compelling Preliminary Data for OCU410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Nov 18	RGNX	Regenxbio surges 10% as it launches pivotal phase of muscular dystrophy asset trial
Nov 18	GILD	Gilead’s Livdelzi shows promise in PBC clinical trial
Nov 18	RGNX	REGENXBIO INITIATES PIVOTAL PHASE OF AFFINITY DUCHENNE® TRIAL OF RGX-202 GENE THERAPY AND REPORTS POSITIVE FUNCTIONAL DATA
Nov 18	RGNX	FDA endorses speedy approval path for Regenxbio Duchenne gene therapy
Nov 15	RGNX	Regenxbio down 13% ahead of data readout for muscular dystrophy asset
Nov 15	GILD	Gilead Unveils Long-Term Data From Seladelpar In Patients With Rare Liver Disease
Nov 15	GILD	Gilead’s Livdelzi (Seladelpar) Demonstrated a Sustained Efficacy and Long-Term Safety Profile in Management of Primary Biliary Cholangitis

Retinitis: Retinitis is inflammation of the retina in the eye, which can permanently damage the retina and lead to blindness. The retina is the part of your eye that is also known as the "sensing tissue." Retinitis may be caused by a number of different infectious agents. Retinitis, also called Retinitis pigmentosa, has a prevalence of one in every 2,500–7,000 people. This condition is one of the leading causes that leads to blindness in patients in the age range of 20–60 years old.
Retinitis may be caused by several infectious agents, including toxoplasmosis, cytomegalovirus and candida. Cytomegalovirus retinitis is an important cause of blindness in AIDS patients, and is the most common cause of vision loss in AIDS patients. Candida may spread to the retina from the bloodstream, which usually leads to the production of several abscesses in the retina.